Clinical Trial Update: Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metronomic neoadjuvant capecitabine and cyclophosphamide in patients with pseudomyxoma peritonei is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomyxoma Peritonei

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Capecitabine (capecitabine)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Pseudomyxoma Peritonei | Phase 2 | Status: RECRUITING